Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9E4Z

GluA2-gamma2 complex bound glutamate and cyclothiazide

Summary for 9E4Z
Entry DOI10.2210/pdb9e4z/pdb
EMDB information47521
DescriptorIsoform Flip of Glutamate receptor 2, Voltage-dependent calcium channel gamma-2 subunit, GLUTAMIC ACID, ... (4 entities in total)
Functional Keywordsligand-gated ion channel, ionotropic glutamate receptor, ampa receptor, ion channel, transport protein
Biological sourceRattus norvegicus (Norway rat)
More
Total number of polymer chains8
Total formula weight458052.72
Authors
Montano Romero, A.,Carrillo, E.,Jayaraman, V.,Twomey, E.C. (deposition date: 2024-10-25, release date: 2025-06-18, Last modification date: 2025-07-16)
Primary citationCarrillo, E.,Montano Romero, A.,Gonzalez, C.U.,Turcu, A.L.,Vazquez, S.,Twomey, E.C.,Jayaraman, V.
Memantine inhibits calcium-permeable AMPA receptors.
Nat Commun, 16:5576-5576, 2025
Cited by
PubMed Abstract: Memantine is an US Food and Drug Administration (FDA) approved drug that is thought to selectively inhibit NMDA-subtype of ionotropic glutamate receptors (NMDARs). NMDARs enable calcium influx into neurons and are critical for normal brain function. However, increasing evidence shows that calcium influx in neurological diseases is augmented by calcium-permeable AMPA-subtype ionotropic glutamate receptors (AMPARs). Here, we demonstrate that these calcium-permeable AMPARs (CP-AMPARs) are inhibited by memantine. Electrophysiology unveils that memantine inhibition of CP-AMPARs is dependent on their calcium permeability and the presence of their neuronal auxiliary subunit transmembrane AMPAR regulatory proteins (TARPs). Through cryo-electron microscopy we elucidate that memantine blocks CP-AMPAR ion channels in a unique mechanism of action from NMDARs. Furthermore, we demonstrate that memantine inhibits a gain of function AMPAR mutation found in a patient with a neurodevelopmental disorder. Our findings unlock potential exploitation of this site to design more specific drugs targeting CP-AMPARs.
PubMed: 40593487
DOI: 10.1038/s41467-025-60543-5
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (3.7 Å)
Structure validation

239492

건을2025-07-30부터공개중

PDB statisticsPDBj update infoContact PDBjnumon